Answer
The most frequently observed skin adverse reactions with regorafenib (Stivarga) are hand-foot skin reaction, also called palmar-plantar erythrodysesthesia syndrome, and rash.
Sources for this answer
- Stivarga 40 mg film coated tabletsBayer plc · emc · SmPC §4.4 Special warnings and precautions for use · Version 7Document updated
Sources checked